Lotensin HCT and Trastuzumab and Hyaluronidase
Determining the interaction of Lotensin HCT and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: benazepril / hydrochlorothiazide
Brand name: Lotensin HCT
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lotensin HCT-Trastuzumab Injection (Intravenous)
- Lotensin HCT-Trastuzumab Intravenous
- Lotensin HCT-Trastuzumab-anns
- Lotensin HCT-Trastuzumab-dkst
- Lotensin HCT-Trastuzumab-dkst Intravenous
- Lotensin HCT-Trasylol
- Trastuzumab and Hyaluronidase-Loteprednol
- Trastuzumab and Hyaluronidase-Loteprednol and Tobramycin
- Trastuzumab and Hyaluronidase-Loteprednol and tobramycin ophthalmic
- Trastuzumab and Hyaluronidase-Loteprednol Etabonate
- Trastuzumab and Hyaluronidase-Loteprednol Eye Drops
- Trastuzumab and Hyaluronidase-Loteprednol Eye Drops 0.2%